ArticleCurrent microbiology2026
Styrene Maleic Acid Lipid Particles Prepared from Mycobacterium tuberculosis Plasma Membrane can Potentially Induce Innate and Adaptive Immune Responses in Healthy Individuals of a Tuberculosis Hyperendemic Region.
Article in Current microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Emerging paradigm suggests that an effective vaccine against tuberculosis (TB) should elicit the necessary innate and adaptive immune responses against Mycobacterium tuberculosis (Mtb). We previously reported that styrene-maleic acid lipid particles (SMALPs) prepared from Mtb plasma membrane (MtM) contain proteins, lipoproteins, and glycolipids capable of inducing these responses in humans. Here, we have evaluated the responses induced by MtM and MtM-SMALPs in fifteen donors of a cohort of healthcare workers from north India. Key cytokines associated with innate (IL-6, TNF-α and IL-1β) and adaptive (IFN-γ) immune responses were assayed by ELISA in the supernatants of blood cultures, which were also used for the determination of T cell proliferative responses by flow cytometry. Serum antibody levels assayed by ELISA served as additional markers of adaptive immunity. MtM-SMALPs enhanced the production of all four cytokines in a concentration-dependent manner whereas higher concentrations of MtM suppressed these responses, significantly for IL-1β. Antibody responses also diverged, with IgM predominating against MtM and IgG against MtM-SMALPs, although overall antibody levels against MtM-SMALPs were low. Together, these findings indicate that MtM-SMALPs are enriched in constituents capable of eliciting the innate and adaptive immunity against Mtb and support further evaluation of SMALPs as a potential vaccine platform.
Indexed as
Identifiers
42645576What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.